Biggest News Aggregation in the World
📰 Ongoing Development News

Page 26 - Ongoing Development News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ongoing Development. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

BioCryst Launches ORLADEYO™ (berotralstat) in Germany

RESEARCH TRIANGLE PARK, N.C., June 03, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that oral, once-daily ORLADEYO™ (berotralstat) is now available for patients with a prescription in Germany. ORLADEYO was approved by the European Medicines Agency (EMA) on April 30, 2021 for the prevention of recurrent hereditary angioedema (HAE) attacks in HAE patients 12 years and older. The full European Summary of Product Characteristics (SMPC) for ORLADEYO is...
Biocryst Pharmaceuticals European Medicines Agency Uropean Summary Of Product Characteristics Hereditary Angioedema Pediatric Patients Moral Therapy
Source: yahoo.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science